-transparent.png){kind=logo}
An open trial of liposomal amphotericin B (AmBisome [L-AmB]; Vestar, San Dimas, CA) for treatment of complicated visceral leishmaniasis was performed in Sudan. Forty-nine patients were treated, and there were six deaths (12% mortality); these were not attributed to therapy. Thirty-seven patients were selected for the trial because of (1) relapse after treatment with a combination of pentavalent antimony (Sbv) and aminosidine, (2) incomplete parasitological response to Sbv and aminosidine, or (3) severe illness. Drug regimen 1 (3 doses of 3-5 mg/kg, on days 0, 3, and 10) cured 8 (50%) of 16 patients; regimen 2 (6 doses of 3-5 mg/kg, on days 0, 3, 6, 8, 10, and 13) cured 14 (88%) of 16. For four of 10 partial responders, "rescue" therapy with L-AmB alone (3 mg/kg daily for 10 days) resulted in cure. Twelve less-unwell patients received regimen 3 (4 doses of 4-5 mg/kg, on days 0, 2, 5, and 7); seven of 11 patients evaluated (64%) were cured. The optimal regimen of L-AmB in these circumstances is administration of 4 mg/kg on days 0, 3, 6, 8, 10, and 13.
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
September 2005,
Annals of tropical medicine and parasitology,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
May 1994,
The Journal of infection,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
November 1993,
Drug and therapeutics bulletin,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
July 1963,
Transactions of the Royal Society of Tropical Medicine and Hygiene,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
January 2014,
PLoS neglected tropical diseases,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
April 1993,
Journal of the Indian Medical Association,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
January 2001,
International journal of antimicrobial agents,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
February 2014,
Tropical medicine & international health : TM & IH,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
May 2008,
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
J Seaman, and
C Boer, and
R Wilkinson, and
J de Jong, and
E de Wilde, and
E Sondorp, and
R Davidson
July 1998,
Journal of clinical pharmacology,
